Therapeutics Sector Q4 Results: Revenue Beats Amid Market Stability

Therapeutics Sector

Q4 revenue beats expectations for 11 tracked firms

Collective revenue beat analyst consensus by 7.1%

Stock prices remain stable despite positive earnings

Stock video by Kost9n4 via Pixabay

Mar 20, 2026

Therapeutics Sector Q4 Results: Revenue Beats Amid Market Stability

A recent sector analysis indicates that a group of eleven tracked therapeutics companies collectively surpassed revenue expectations in the final quarter. The cohort exceeded analyst consensus estimates by 7.1%.

Despite this positive earnings news, the share prices for these firms have remained largely stable on average since their results were announced. The industry is positioned for potential growth in the coming years, supported by progress in precision medicine and increasing demand for rare disease treatments. Concurrent challenges include heightened examination of drug costs, regulatory uncertainties, and competitive pressure from larger pharmaceutical entities.

Moderna Shows Divergent Performance

Moderna (MRNA), known for its mRNA-based therapeutic platform, reported quarterly revenues of $678 million. This figure represents a significant year-over-year decline but still came in 2.7% above what analysts had projected. The company's overall performance for the period was described as exceptional, with beats on both earnings per share and revenue targets.

Notably, Moderna posted the slowest revenue growth within the peer group. However, its stock has appreciated substantially since the earnings release.

Novavax Leads Peers in Quarterly Growth

Novavax (NVAX), a vaccine developer utilizing nanoparticle technology, reported the strongest performance among the group. Its revenue increased markedly year over year to $147.1 million, surpassing analyst forecasts by 57.4%. The period was characterized as incredible, with the company exceeding expectations for both earnings per share and revenue.

Novavax achieved the fastest revenue growth and the largest positive surprise relative to estimates within the sector. Its stock price has seen a modest increase following the report.

This report provides a comprehensive view of the global vaccines industry, tracking demand, supply, and trade flows across the worldwide value chain. It explains how demand across key channels and end-use segments shapes consumption patterns, while also mapping the role of input availability, production efficiency, and regulatory standards on supply.

Beyond headline metrics, the study benchmarks prices, margins, and trade routes so you can see where value is created and how it moves between exporters and importers worldwide. The analysis is designed to support strategic planning, market entry, portfolio prioritization, and risk management in the global vaccines landscape.

Quick navigation

Key findings
Report scope
Product coverage
Country coverage
Methodology
Forecasts to 2035
Price analysis
Market participants
Country profiles
How to use this report
FAQ

Key findings

Global demand is shaped by both household and industrial usage, with trade flows linking cost-competitive producers to import-reliant markets.
Pricing dynamics reflect unit values, freight costs, exchange rates, and regulatory shifts that affect sourcing decisions.
Supply depends on input availability and production efficiency, creating distinct cost curves across regions.
Market concentration varies by country, creating different competitive landscapes and entry barriers.
The 2035 outlook highlights where capacity investment and demand growth are most aligned globally.

Report scope

The report combines market sizing with trade intelligence and price analytics. It covers both historical performance and the forward outlook to 2035, allowing you to compare cycles, structural shifts, and policy impacts across countries and regions.

Market size and growth in value and volume terms
Consumption structure by end-use segments and regions
Production capacity, output, and cost dynamics
Global trade flows, exporters, importers, and balances
Price benchmarks, unit values, and margin signals
Competitive context and market entry conditions

Product coverage

Prodcom 21202145 - Vaccines for human medicine

Country coverage

Country profiles and benchmarks

For the global report, country profiles provide a consistent view of market size, trade balance, prices, and per-capita indicators. The profiles highlight the largest consuming and producing markets and allow direct benchmarking across peers.

Methodology

The analysis is built on a multi-source framework that combines official statistics, trade records, company disclosures, and expert validation. Data are standardized, reconciled, and cross-checked to ensure consistency across time series.

International trade data (exports, imports, and mirror statistics)
National production and consumption statistics
Company-level information from financial filings and public releases
Price series and unit value benchmarks
Analyst review, outlier checks, and time-series validation

All data are normalized to a common product definition and mapped to a consistent set of codes. This ensures that comparisons across time are aligned and actionable.

Forecasts to 2035

The forecast horizon extends to 2035 and is based on a structured model that links vaccines demand and supply to macroeconomic indicators, trade patterns, and sector-specific drivers. The model captures both cyclical and structural factors and reflects known policy and technology shifts.

Historical baseline: 2012-2025
Forecast horizon: 2026-2035
Scenario-based sensitivity to income growth, substitution, and regulation
Capacity and investment outlook for major producing countries

Each country projection is built from its own historical pattern and the regional context, allowing the report to show where growth is concentrated and where risks are elevated.

Price analysis and trade dynamics

Prices are analyzed in detail, including export and import unit values, regional spreads, and changes in trade costs. The report highlights how seasonality, freight rates, exchange rates, and supply disruptions influence pricing and margins.

Price benchmarks by country and sub-region
Export and import unit value trends
Seasonality and calendar effects in trade flows
Price outlook to 2035 under baseline assumptions

Profiles of market participants

Key producers, exporters, and distributors are profiled with a focus on their operational scale, geographic footprint, product mix, and market positioning. This helps identify competitive pressure points, partnership opportunities, and routes to differentiation.

Business focus and production capabilities
Geographic reach and distribution networks
Cost structure and pricing strategy indicators
Compliance, certification, and sustainability context

How to use this report

Quantify global demand and identify the most attractive markets
Evaluate export opportunities and prioritize target countries
Track price dynamics and protect margins
Benchmark performance against major competitors
Build evidence-based forecasts for investment decisions

This report is designed for manufacturers, distributors, importers, wholesalers, investors, and advisors who need a clear, data-driven picture of global vaccines dynamics.

FAQ

What is included in the global vaccines market?

The market size aggregates consumption and trade data at country and regional levels, presented in both value and volume terms.

How are the forecasts to 2035 built?

The projections combine historical trends with macroeconomic indicators, trade dynamics, and sector-specific drivers.

Does the report cover prices and margins?

Yes, it includes export and import unit values, regional spreads, and a pricing outlook to 2035.

Which countries are profiled in detail?

The report provides profiles for the largest consuming and producing countries, enabling benchmarking across peers.

Can this report support market entry decisions?

Yes, it highlights demand hotspots, trade routes, pricing trends, and competitive context.

1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business
1. REPORT DESCRIPTION
2. RESEARCH METHODOLOGY AND THE AI PLATFORM
3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
4. GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance
1. KEY FINDINGS
2. MARKET TRENDS This Chapter is Available Only for the Professional EditionPRO
3. MARKET OVERVIEW

Understanding the Current State of The Market and its Prospects
1. MARKET SIZE: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
2. CONSUMPTION BY COUNTRY: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
3. MARKET FORECAST TO 2035
4. MOST PROMISING PRODUCTS FOR DIVERSIFICATION

Finding New Products to Diversify Your Business
- This Chapter is Available Only for the Professional EditionPRO
1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
2. BEST-SELLING PRODUCTS
3. MOST CONSUMED PRODUCTS
4. MOST TRADED PRODUCTS
5. MOST PROFITABLE PRODUCTS FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain
- This Chapter is Available Only for the Professional EditionPRO
1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
2. TOP PRODUCING COUNTRIES
3. TOP EXPORTING COUNTRIES
4. LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Export
- This Chapter is Available Only for the Professional EditionPRO
1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
2. TOP CONSUMING MARKETS
3. UNSATURATED MARKETS
4. TOP IMPORTING MARKETS
5. MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry
1. PRODUCTION VOLUME AND VALUE: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
2. PRODUCTION BY COUNTRY: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
8. IMPORTS

The Largest Import Supplying Countries
1. IMPORTS: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
2. IMPORTS BY COUNTRY: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
3. IMPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
9. EXPORTS

The Largest Destinations for Exports
1. EXPORTS: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
2. EXPORTS BY COUNTRY: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
3. EXPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles
- This Chapter is Available Only for the Professional EditionPRO
11. COUNTRY PROFILES

The Largest Markets And Their Profiles
This Chapter is Available Only for the Professional Edition PRO
1. 11.1
  United States
  - Market Size
  - Production
  - Imports
  - Exports
2. 11.2
  China
  - Market Size
  - Production
  - Imports
  - Exports
3. 11.3
  Japan
  - Market Size
  - Production
  - Imports
  - Exports
4. 11.4
  Germany
  - Market Size
  - Production
  - Imports
  - Exports
5. 11.5
  United Kingdom
  - Market Size
  - Production
  - Imports
  - Exports
6. 11.6
  France
  - Market Size
  - Production
  - Imports
  - Exports
7. 11.7
  Brazil
  - Market Size
  - Production
  - Imports
  - Exports
8. 11.8
  Italy
  - Market Size
  - Production
  - Imports
  - Exports
9. 11.9
  Russian Federation
  - Market Size
  - Production
  - Imports
  - Exports
10. 11.10
  India
  - Market Size
  - Production
  - Imports
  - Exports
11. 11.11
  Canada
  - Market Size
  - Production
  - Imports
  - Exports
12. 11.12
  Australia
  - Market Size
  - Production
  - Imports
  - Exports
13. 11.13
  Republic of Korea
  - Market Size
  - Production
  - Imports
  - Exports
14. 11.14
  Spain
  - Market Size
  - Production
  - Imports
  - Exports
15. 11.15
  Mexico
  - Market Size
  - Production
  - Imports
  - Exports
16. 11.16
  Indonesia
  - Market Size
  - Production
  - Imports
  - Exports
17. 11.17
  Netherlands
  - Market Size
  - Production
  - Imports
  - Exports
18. 11.18
  Turkey
  - Market Size
  - Production
  - Imports
  - Exports
19. 11.19
  Saudi Arabia
  - Market Size
  - Production
  - Imports
  - Exports
20. 11.20
  Switzerland
  - Market Size
  - Production
  - Imports
  - Exports
21. 11.21
  Sweden
  - Market Size
  - Production
  - Imports
  - Exports
22. 11.22
  Nigeria
  - Market Size
  - Production
  - Imports
  - Exports
23. 11.23
  Poland
  - Market Size
  - Production
  - Imports
  - Exports
24. 11.24
  Belgium
  - Market Size
  - Production
  - Imports
  - Exports
25. 11.25
  Argentina
  - Market Size
  - Production
  - Imports
  - Exports
26. 11.26
  Norway
  - Market Size
  - Production
  - Imports
  - Exports
27. 11.27
  Austria
  - Market Size
  - Production
  - Imports
  - Exports
28. 11.28
  Thailand
  - Market Size
  - Production
  - Imports
  - Exports
29. 11.29
  United Arab Emirates
  - Market Size
  - Production
  - Imports
  - Exports
30. 11.30
  Colombia
  - Market Size
  - Production
  - Imports
  - Exports
31. 11.31
  Denmark
  - Market Size
  - Production
  - Imports
  - Exports
32. 11.32
  South Africa
  - Market Size
  - Production
  - Imports
  - Exports
33. 11.33
  Malaysia
  - Market Size
  - Production
  - Imports
  - Exports
34. 11.34
  Israel
  - Market Size
  - Production
  - Imports
  - Exports
35. 11.35
  Singapore
  - Market Size
  - Production
  - Imports
  - Exports
36. 11.36
  Egypt
  - Market Size
  - Production
  - Imports
  - Exports
37. 11.37
  Philippines
  - Market Size
  - Production
  - Imports
  - Exports
38. 11.38
  Finland
  - Market Size
  - Production
  - Imports
  - Exports
39. 11.39
  Chile
  - Market Size
  - Production
  - Imports
  - Exports
40. 11.40
  Ireland
  - Market Size
  - Production
  - Imports
  - Exports
41. 11.41
  Pakistan
  - Market Size
  - Production
  - Imports
  - Exports
42. 11.42
  Greece
  - Market Size
  - Production
  - Imports
  - Exports
43. 11.43
  Portugal
  - Market Size
  - Production
  - Imports
  - Exports
44. 11.44
  Kazakhstan
  - Market Size
  - Production
  - Imports
  - Exports
45. 11.45
  Algeria
  - Market Size
  - Production
  - Imports
  - Exports
46. 11.46
  Czech Republic
  - Market Size
  - Production
  - Imports
  - Exports
47. 11.47
  Qatar
  - Market Size
  - Production
  - Imports
  - Exports
48. 11.48
  Peru
  - Market Size
  - Production
  - Imports
  - Exports
49. 11.49
  Romania
  - Market Size
  - Production
  - Imports
  - Exports
50. 11.50
  Vietnam
  - Market Size
  - Production
  - Imports
  - Exports
LIST OF TABLES
1. Key Findings In 2025
2. Market Volume, In Physical Terms: Historical Data (2012–2025) and Forecast (2026–2035)
3. Market Value: Historical Data (2012–2025) and Forecast (2026–2035)
4. Per Capita Consumption, by Country, 2022–2025
5. Production, In Physical Terms, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
6. Imports, In Physical Terms, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
7. Imports, In Value Terms, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
8. Import Prices, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
9. Exports, In Physical Terms, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
10. Exports, In Value Terms, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
11. Export Prices, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
LIST OF FIGURES
1. Market Volume, In Physical Terms: Historical Data (2012–2025) and Forecast (2026–2035)
2. Market Value: Historical Data (2012–2025) and Forecast (2026–2035)
3. Consumption, by Country, 2025
4. Market Volume Forecast to 2035
5. Market Value Forecast to 2035
6. Market Size and Growth, By Product
7. Average Per Capita Consumption, By Product
8. Exports and Growth, By Product
9. Export Prices and Growth, By Product
10. Production Volume and Growth
11. Exports and Growth
12. Export Prices and Growth
13. Market Size and Growth
14. Per Capita Consumption
15. Imports and Growth
16. Import Prices
17. Production, In Physical Terms: Historical Data (2012–2025) and Forecast (2026–2035)
18. Production, In Value Terms: Historical Data (2012–2025) and Forecast (2026–2035)
19. Production, by Country, 2025
20. Production, In Physical Terms, by Country: Historical Data (2012–2025) and Forecast (2026–2035)
21. Imports, In Physical Terms: Historical Data (2012–2025) and Forecast (2026–2035)
22. Imports, In Value Terms: Historical Data (2012–2025) and Forecast (2026–2035)
23. Imports, In Physical Terms, By Country, 2025
24. Imports, In Physical Terms, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
25. Imports, In Value Terms, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
26. Import Prices, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
27. Exports, In Physical Terms: Historical Data (2012–2025) and Forecast (2026–2035)
28. Exports, In Value Terms: Historical Data (2012–2025) and Forecast (2026–2035)
29. Exports, In Physical Terms, By Country, 2025
30. Exports, In Physical Terms, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
31. Exports, In Value Terms, By Country: Historical Data (2012–2025) and Forecast (2026–2035)
32. Export Prices, By Country: Historical Data (2012–2025) and Forecast (2026–2035)

Recommended posts

Kynam Capital Reduces Cogent Biosciences Stake in Q4 2025

Kynam Capital Sells $43.8M in CG Oncology Shares, Reduces Stake to 2.51%

Pfizer and Moderna Seek Turnaround as Vaccine Sales Decline

How to Convert Market Analysis into a Decision-Ready Management Memo